Diabetes

Treating patients with type 2 diabetes mellitus just got a little easier.

A potential Ebola outbreak in Senegal was snuffed out thanks in part to an innovative text-messaging program originally intended to help patients with diabetes manage their disease.

The new Diabetes Health Coach creates a personalized experience designed to help people living with diabetes improve their diabetes management.

The City of Houston and Novo Nordisk today announced an innovative partnership to fight the urban diabetes epidemic. Houston is the third city globally and the first in the United States to join the Cities Changing Diabetes programme, which was initiated earlier in 2014 by Novo Nordisk. The first two cities are Mexico City and Copenhagen.

The dangers of failing to change the clocks on insulin pumps in recognition of daylight saving time.

Fifteen hospitals that use insulin pens will participate in ASHP's Mentored Quality Improvement Impact Program for Insulin Pen Safety.

Xigduo XR combines 2 anti-hyperglycemic agents with complementary mechanisms of action.

Women who develop gestational diabetes mellitus tend to have daughters who become obese later in childhood.

Draft guidance by the United States Preventive Services Task Force advocates screening patients with certain risk factors for impaired glucose tolerance to delay or prevent the onset of, and long-term damage due to, T2DM.

The rate of type 1 diabetes mellitus among non-Hispanic white youth increased significantly over an 8-year period.

Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.

Children infected with enterovirus have a 48% increased risk of developing type 1 diabetes.

Many cardiologists and pharmacists are concerned about clopidogrel, especially when it is prescribed for patients with diabetes.

Medication omission at discharge is the most common type of medication discrepancy.

Even a modest weight loss can improve overall health.

Even a modest weight loss can improve overall health.

The FDA has granted priority review to Roche's injectable ranibizumab (Lucentis) treatment for diabetic retinopathy.

A practical approach to daily life with the support of a pharmacist can make a difference.

Patients with diabetes may not know about OTC products formulated to meet their specific needs.

The FDA has approved the intravitreal implant, Iluvien 0.19 mg, as the first long-term treatment for diabetic macular edema.

The dexamethasone intravitreal implant, Ozurdex, is now indicated to treat all patients with diabetic macular edema.

Pharmacists who participate in community-based diabetes care teams play a pivotal role in reducing A1C levels among patients with poorly controlled diabetes.